
|Videos|March 17, 2023
Emma Guttman-Yassky of Icahn School of Medicine Talks Developments in Atopic Dermatitis Treatment
Emma Guttman-Yassky, M.D., Ph.D. of Icahn School of Medicine at Mount Sinai, New York discussed developments in atopic dermatitis treatment, more specifically with therapies like rocatinlimab and other anti-OX4 agents today at the annual American Academy of Dermatology meeting in New Orleans.
Advertisement
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Atopic Dermatitis Treatment in Infants Should Not Wait | Fall Clinical Derm 2025
2
Addressing Complex Dermatologic Conditions in Children | Fall Clinical Derm 2025
3
Icotrokinra Demonstrates High Clearance Rates in Plaque Psoriasis | Fall Clinical Derm 2025
4
Shawn Kwatra, M.D. Highlights Challenges in Treating Complex Skin Conditions | Fall Clinical Derm 2025
5
















































